Top 14+ Cb-839 Hcl hay nhất
-
1.Testing Of The Anti Cancer Drugs CB-839 HCl (Telaglenastat) And ...
31 Jan 2020 · This phase I/Ib trial studies the side effects and best dose of CB-839 HCl when given together with sapanisertib in treating patients with ...
Xem chi tiết » -
2.CB-839 HCl In Combination With Carfilzomib And Dexamethasone ...
10 Jan 2019 · This phase I trial studies the best dose of CB-839 HCl when given together with carfilzomib and dexamethasone in treating patients with ...
Xem chi tiết » -
3.Phase 1 Trial Of MLN0128 (Sapanisertib) And CB-839 HCl ... - PubMed
This phase 1 study will determine the recommended expansion dose and preliminary efficacy of MLN0128 and CB-839 in advanced non-small-cell lung cancer with ...
Xem chi tiết » -
4.A Phase 1 Trial Of MLN0128 (sapanisertib) And CB-839 HCl ... - NCBI
16 Oct 2020 · CB-839 HCl (telaglenastat) is a first in class oral glutaminase inhibitor that blocks tumor glutamine consumption. Glutaminase inhibitors have ...
Xem chi tiết » -
5.Phase 1 Trial Of MLN0128 (Sapanisertib) And CB-839 HCl ...
CB-839 HCl (telaglenastat) is a first-in-class oral glutaminase inhibitor that blocks tumor glutamine consumption. Glutaminase inhibitors have synergistic ...
Xem chi tiết » -
6.Trial In Progress: Phase I Dose-Escalation And Dose-Expansion ...
13 Nov 2019 · Trial in Progress: Phase I Dose-Escalation and Dose-Expansion Trial of a Novel Glutaminase Inhibitor (CB-839 HCl) in Combination with ...
Xem chi tiết » -
7.Phase 1 Trial Of MLN0128 (Sapanisertib) And CB-839 HCl ...
5 Oct 2020 · CB-839 HCl (Telaglenastat) in Patients With. Advanced NSCLC (NCI 10327): Rationale and. Study Design. Jonathan W. Riess,. 1. Paul Frankel,.
Xem chi tiết » -
8.A Phase I/II Study Of AZD9291 (Osimertinib) And CB-839 ...
Winter. A Phase I/II Study of AZD9291 (Osimertinib) and CB-839 Hydrochloride HCl in Patients With EGFR-Mutant Non-Small Cell Lung Cancer.
Xem chi tiết » -
9.Testing Whether Cancers With Specific Mutations Respond Better To ...
... Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study. ... how well glutaminase inhibitor telaglenastat hydrochloride (CB-839 HCl) works in ...
Xem chi tiết » -
10.Telaglenastat (CB-839) - Glutaminase Inhibitor
Telaglenastat (CB-839) is a potent, selective, and orally bioavailable glutaminase inhibitor with IC50 of 24 nM for recombinant human GAC.
Xem chi tiết » -
11.A Phase Ib Study Of AZD9291 (Osimertinib) And CB-839 HCl In ...
A Phase Ib Study of AZD9291 (Osimertinib) and CB-839 HCl in Patients with EGFR Mutant Non-Small Cell Lung Cancer – ETCTN 10216. UVA Tracking #. HSR200081.
Xem chi tiết » -
12.A Study To Evaluate CB-839 HCl In Combination With Carfilzomib ...
CB-839 HCl and carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...
Xem chi tiết » -
13.Safety And Tolerability Of Increasing Doses Of CB-839, A First-in-class ...
20 May 2015 · 2512 Background: Glutamine is required for the growth and survival of multiple tumor types. CB-839 is a highly selective, reversible, ...
Xem chi tiết » -
14.Testing Of The Anti Cancer Drugs CB-839 HCl ... - CenterWatch
This phase I/Ib trial studies the side effects and best dose of CB-839 HCl when given together with sapanisertib in treating patients with non-small cell ...
Xem chi tiết »